Global Blood Therapeutics (GBT) PT Raised to $120 at Stifel Post Physician Survey
Tweet Send to a Friend
Stifel analyst Benjamin Burnett raised the price target on Global Blood Therapeutics (NASDAQ: GBT) to $120.00 (from $118.00) after surveying ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
